You are here
Dova Pharmaceuticals to Present at Upcoming Investor Conferences
DURHAM, N.C., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that the management team will present a company overview at four upcoming investor conferences:
- On Tuesday, November 13, 2018, Dova will present at the Stifel 2018 Healthcare Conference at 11:45 am ET in New York, NY.
- On Tuesday, November 13, 2018, Dova will present at the Credit Suisse 27th Annual Healthcare Conference at 2:15 pm MT in Scottsdale, AZ.
- On Thursday, November 15, 2018, Dova will present at the Jefferies 2018 London Healthcare Conference at 10:00 am GMT in London, UK.
- On Tuesday, November 27, 2018, Dova will present at the Evercore ISI HealthconX Conference at 9:05 am ET in Boston, MA.
A live audio webcast of each event will be available via the "Investor Relations" page of the Dova website, www.dova.com. Please log on through Dova's website approximately 10 minutes before the scheduled start times. A replay of each webcast will be archived on Dova's website for 90 days following the call.
About Dova Pharmaceuticals, Inc.
Dova is a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases where there is a high unmet need, with an initial focus on addressing thrombocytopenia. Dova’s proprietary pipeline includes one commercial product, DOPTELET, for the treatment of thrombocytopenia in adult patients with chronic liver disease to undergo a procedure.
Mark W. Hahn
Chief Financial Officer